Can Longevity Supplements Interact With Common Senior Dog Medications?

On this page

1. What actually happens biochemically
2. NSAIDs, anticoagulants, and the drugs that actually matter here
3. Where resveratrol’s evidence base actually stops
4. What I’d actually tell an owner

Here’s the fork every owner of an aging dog eventually hits: your twelve-year-old is already on an NSAID for hip arthritis, and now you’re holding a longevity chew that promises better energy and sharper cognition. Do you add it, or do you call the clinic first? I’ve had this exact conversation across an exam table more times than I can count, and I don’t think the honest answer is “just try it and see.”

A ten-year-old, 62-pound Labrador mix comes in three weeks into a carprofen prescription for osteoarthritis. His owner, encouraged by a friend’s results, had started a resveratrol-quercetin longevity chew the same week — no washout, no phone call first. Nothing acute happened. But at his three-week recheck, his platelet function panel came back mildly sluggish, and we couldn’t fully separate the drug from the supplement as the cause. That’s not a horror story; it’s the ordinary, unglamorous reason timing matters more than most owners assume.

What actually happens biochemically

Two of the most common longevity ingredients — resveratrol and quercetin — aren’t biochemically inert passengers. They’re metabolized through the same liver pathways that clear many prescription drugs. In human liver microsome studies, resveratrol showed stereoselective inhibition of CYP2C9, CYP3A, and UGT1A1 enzymes, the same family responsible for breaking down a wide range of medications, according to a study published on PubMed Central. Quercetin has separately been shown to suppress P-glycoprotein, a transporter protein that controls how much of a drug gets absorbed and how quickly it’s cleared. Slow that clearance down, even modestly, and a stable NSAID or heart medication dose can behave differently than the label assumes.

None of that is a reason to panic over a chew. It’s a reason to treat “longevity supplement” the way you’d treat any other substance going into a dog already on prescription drugs: a variable that needs tracking, not an assumed neutral. I keep coming back to joints because that’s where I see this collide most often — a dog on long-term NSAID therapy for osteoarthritis is, by definition, a dog whose liver and kidneys are already doing extra metabolic work. Adding an enzyme-inhibiting ingredient on top of that isn’t dangerous by default, but it’s not nothing either.

NSAIDs, anticoagulants, and the drugs that actually matter here

Not every senior medication carries the same interaction risk. The ones I flag first:

• NSAIDs (carprofen, meloxicam, deracoxib) — already metabolized through CYP pathways; enzyme-inhibiting supplements can raise effective drug exposure.
• Anticoagulants or dogs with clotting disorders — resveratrol’s mild antiplatelet activity is a bigger deal here than in a healthy dog.
• Phenobarbital and other liver-cleared seizure medications — anything that competes for the same enzymes is worth a blood-level check, not a guess.

The FDA’s guidance for veterinarians on NSAID pain control is blunt about the underlying principle: owners are supposed to disclose every medication, supplement, and topical product a dog is taking, because the vet is the one positioned to catch a compounding effect before it becomes a lab abnormality. That disclosure step is the actual safety mechanism — not the supplement label, not the marketing copy.

Quercetin itself has a reasonably conservative evidence base at the doses used in dog chews. It’s a flavonoid with antioxidant properties studied for immune and cellular support, and the interaction concern scales with dose and duration, not with a single serving. Separately, in vitro nematode work found that quercetin at the tested concentrations did not affect feeding behavior, according to Pharmaceuticals (DOI.3390/ph19040525), which tells you about basic tolerability in that model system, not about drug metabolism in a dog on carprofen — a distinction worth holding onto, because “well-tolerated alone” and “safe alongside a specific prescription” are two different claims.

A different case complicates the picture further. A fourteen-year-old, 18-pound terrier on long-term phenobarbital for seizure control started an NAD+ precursor chew at his owner’s initiative, with no interaction reported over the following two months of monitored bloodwork. That’s not proof the combination is safe in general — it’s one data point, in one small dog, at one dose, with active veterinary oversight the whole time. I bring it up because it cuts against the instinct to treat every enzyme-metabolized supplement as automatically dangerous. The risk is real but it’s not uniform, and blanket avoidance isn’t more defensible than blanket permission.

Where resveratrol’s evidence base actually stops

Resveratrol’s cellular-health story is genuinely interesting, but the interaction data comes almost entirely from human and in vitro pharmacology, not from controlled canine trials on dogs taking specific senior medications. According to Phytomedicine (DOI.1016/j.phymed.2026.158531), one study following embryonic exposure to resveratrol found that a moderate dose accelerated developmental timing but shortened adult lifespan in the model organism tested — a reminder that “more antioxidant” doesn’t reliably mean “more benefit,” and that dose-response curves for these compounds aren’t simply linear. That finding doesn’t map directly onto an adult dog’s physiology, but it’s a useful check on the assumption that longevity ingredients are risk-free simply because they’re framed as supportive rather than pharmaceutical.

What I’d actually tell an owner

Three things, in order. First, tell your vet before you start, not after — a thirty-second conversation at a recheck costs nothing and catches almost every real problem. Second, if your dog is on an NSAID, an anticoagulant, or a liver-cleared seizure medication, ask specifically whether a baseline and follow-up bloodwork check makes sense a few weeks in. Third, favor products that carry the NASC Quality Seal, since that certification requires an adverse-event reporting system as part of maintaining the seal, according to NASC — it doesn’t guarantee zero interactions, but it means a company is structurally required to track and respond to problems instead of just collecting five-star reviews.

If you want a rubric for comparing specific chews before you buy, our team scored several head-to-head in Best Longevity Supplement for Senior Dogs: 5 NAD+ Chews, Ranked by a Vet and again in The Best NAD+ Supplement for Dogs: 4 Senior-Longevity Picks, Scored. If your dog is already showing the kind of slowdown that makes this decision urgent, Senior Dog Slowing Down? The Supplements With Real Evidence Behind Them is a better starting point than a leaderboard. And if dosing math for a larger dog is part of your hesitation, How Many Longevity Chews Can a 90-lb Large Dog Have Per Day? walks through it directly.

None of this is a reason to avoid longevity supplements outright in a medicated senior dog. It’s a reason to sequence the decision correctly — vet conversation first, bloodwork check second, product choice third — instead of backward.

Frequently asked questions

Can I give my dog a longevity supplement while they're on an NSAID like carprofen or meloxicam?

Often yes, but tell your vet first. Both resveratrol and quercetin are metabolized through liver enzyme pathways that also clear NSAIDs, so a baseline check and a follow-up recheck a few weeks in are reasonable precautions rather than overreactions.

Are NAD+ precursor chews riskier than antioxidant blends for a medicated senior dog?

Not inherently. Nicotinamide riboside supports normal cellular function as an NAD+ precursor and isn't the primary enzyme-inhibiting concern in most interaction discussions; resveratrol and quercetin's effects on CYP450 and P-glycoprotein are the more established concern.

What's the single best safeguard against a supplement-drug interaction?

Disclosure. Tell your veterinarian every supplement your dog is taking, at every visit, not just at intake — that's the mechanism the FDA's own guidance points to as the actual safety net.

Sources

1. Stereoselective Food Drug Interaction Potential of Resveratrol on Nine P450 and Six UGT Isoforms in Human Liver Microsomes — PubMed Central
2. What Veterinarians Should Advise Clients About Pain Control and Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) in Dogs and Cats — FDA
3. NASC Quality Seal — NASC
4. Quercetin feeding behavior study — Pharmaceuticals (DOI:10.3390/ph19040525)
5. Embryonic resveratrol exposure and lifespan — Phytomedicine (DOI:10.1016/j.phymed.2026.158531)